Spermatogonia represent the initial stage of the male germ cell lineage and play a fundamental role in spermatogenesis—the process of sperm cell formation within the testes. These diploid cells reside in the seminiferous tubules and undergo mitotic divisions to replenish the pool of germ cells continuously. There are two types of spermatogonia: Type A, which are undifferentiated and maintain the stem cell population, and Type B, which undergo differentiation to eventually give rise to spermatozoa. Spermatogonia are regulated by hormonal signals, including follicle-stimulating hormone (FSH) and testosterone, which influence their proliferation and differentiation. The process of spermatogonial differentiation involves the transition from spermatogonium to primary spermatocyte, marking the initiation of meiosis. This complex and highly regulated sequence of events ensures the production of functional sperm with the correct chromosome number. Spermatogonia are integral to male fertility, and abnormalities in their function can lead to reproductive disorders. Studying spermatogonia is crucial for understanding the molecular mechanisms underlying spermatogenesis, as well as for developing strategies to address male infertility and improve assisted reproductive technologies. Advances in reproductive biology continue to unveil the intricate details of spermatogonial function, contributing to both clinical applications and broader insights into male reproductive health.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States